Related Experiment Videos
Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease
L A Bindoff1, M A Birch-Machin, N E Cartlidge
1Division of Clinical Neuroscience, Medical School, University of Newcastle upon Tyne, U.K.
Abstract:
Parkinson's disease is one of the commonest neurodegenerative disorders in Western society. Although the neuropathological changes have been well documented, the underlying biochemical defect is unknown. Toxins may play a part in the aetiology of this disorder. It has been shown that 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) produces a Parkinson-like syndrome in both man and primates and 1-methyl-4-phenylpyridine (MPP+), a metabolite of MPTP, inhibits NADH-ubiquinone oxidoreductase (complex I) of the mitochondrial respiratory chain. We studied mitochondrial respiratory chain function in skeletal muscle from patients with Parkinson's disease because, like brain, it has a high dependence on oxidative metabolism. Our results show low activity in all complexes studied (I, II and IV). The implications of these findings are discussed in relation to the aetiology of Parkinson's disease.
Insights
Parkinson's disease patients show reduced mitochondrial function in skeletal muscle. This suggests impaired energy production may contribute to this neurodegenerative disorder.
Area of Science:
- Neuroscience
- Biochemistry
- Cellular Metabolism
Background:
- Parkinson's disease (PD) is a prevalent neurodegenerative disorder with unknown biochemical origins.
- Environmental toxins, such as 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), can induce Parkinsonism.
- MPTP's metabolite, 1-methyl-4-phenylpyridine (MPP+), inhibits mitochondrial complex I, crucial for cellular respiration.
Observation:
- Mitochondrial respiratory chain function was investigated in skeletal muscle biopsies from Parkinson's disease patients.
- Skeletal muscle was chosen due to its high reliance on oxidative metabolism, similar to brain tissue.
- Activity levels of key mitochondrial complexes (I, II, and IV) were assessed.
Findings:
- Patients with Parkinson's disease exhibited significantly reduced activity across multiple mitochondrial respiratory chain complexes (I, II, and IV).
- This widespread impairment indicates a systemic issue with cellular energy production in PD.
- The observed mitochondrial dysfunction in skeletal muscle mirrors findings in the central nervous system.
Implications:
- The findings suggest that impaired mitochondrial respiration in skeletal muscle could be a contributing factor to Parkinson's disease aetiology.
- This research opens avenues for exploring mitochondrial dysfunction as a therapeutic target for Parkinson's disease.
- Further investigation into the link between mitochondrial defects and neurodegeneration in PD is warranted.